DWP
MRNA icon

Destiny Wealth Partners’s Moderna MRNA Stock Holding History

Destiny Wealth Partners’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.23K Buy
+103
New +$4.8K ﹤0.01% 976
2024
Q3 		– Sell
-2,000
Closed -$238K – 163
2024
Q2 		$238K Hold
2,000
– – 0.04% 142
2024
Q1 		$213K Hold
2,000
– – 0.04% 151
2023
Q4 		$217K Sell
2,000
-10
-0.5% -$841 0.04% 149
2023
Q3 		$208K Hold
2,010
– – 0.04% 158
2023
Q2 		$254K Hold
2,010
– – 0.05% 144
2023
Q1 		$309K Hold
2,010
– – 0.06% 131
2022
Q4 		$361K Hold
2,010
– – 0.08% 120
2022
Q3 		$238K Buy
2,010
+2,000
+20,000% +$303K 0.05% 174
2022
Q2 		$1K Hold
10
– – ﹤0.01% 588
2022
Q1 		$2K Hold
10
– – ﹤0.01% 494
2021
Q4 		$3K Hold
10
– – ﹤0.01% 501
2021
Q3 		$4K Buy
+10
New +$3.69K ﹤0.01% 471
2021
Q1 		– Sell
-13
Closed -$1K – 559
2020
Q4 		$1K Buy
+13
New +$1.31K ﹤0.01% 499

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return